Rongjun Liu1, Baikai Ma1, Yufei Gao1, Boping Ma1, Yiyun Liu1, Hong Qi2. 1. Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China. 2. Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China. Electronic address: doctorqihong@163.com.
Abstract
PURPOSE: To enhance the understanding of dry eye (DE) in diabetes by evaluating the ocular surface characteristics and the levels of tear inflammatory cytokines. DESIGN: Cross-sectional study. METHODS: Subjects were divided into 4 groups: 32 patients in the diabetes with DE group; 24 patients in the diabetes without DE group; 28 patients in the nondiabetes with DE group; and 29 volunteers in the normal group. Ocular surface disease index (OSDI) was self-answered and ocular surface characteristics including tear film break-up time (BUT), Schirmer I test, corneal fluorescein staining (CFS), and corneal sensitivity were evaluated. Concentrations of epidermal growth factor (EGF), IL-17A, IL-1β, and tumor necrosis factor alpha (TNF-α) were measured by mutiplex bead analysis. Spearman correlations between cytokines and ocular surface parameters were calculated. RESULTS: The level of EGF in tears significantly increased in the diabetes with DE group and positively correlated with the CFS and negatively correlated with the Schirmer I test in this group (P < .05). No differences were found in the levels of IL-17A, IL-1β, and TNF-α in the diabetes with DE and diabetes without DE groups compared to the normal group (P > .05). The nondiabetes with DE group showed increased levels of IL-17A, IL-1β, and TNF-α in tears compared to the normal group and the levels of IL-1β and TNF-α in tears positively correlated with CFS (P < .05). CONCLUSIONS: Our study showed that levels of EGF in tears have potential to be the diagnostic biomarker of DE in diabetes. No differences of IL-17A, IL-1β, and TNF-α in tears were found between the diabetes with DE and normal group, suggesting different pathogenesis of diabetes DE vs nondiabetes DE.
PURPOSE: To enhance the understanding of dry eye (DE) in diabetes by evaluating the ocular surface characteristics and the levels of tear inflammatory cytokines. DESIGN: Cross-sectional study. METHODS: Subjects were divided into 4 groups: 32 patients in the diabetes with DE group; 24 patients in the diabetes without DE group; 28 patients in the nondiabetes with DE group; and 29 volunteers in the normal group. Ocular surface disease index (OSDI) was self-answered and ocular surface characteristics including tear film break-up time (BUT), Schirmer I test, corneal fluorescein staining (CFS), and corneal sensitivity were evaluated. Concentrations of epidermal growth factor (EGF), IL-17A, IL-1β, and tumor necrosis factor alpha (TNF-α) were measured by mutiplex bead analysis. Spearman correlations between cytokines and ocular surface parameters were calculated. RESULTS: The level of EGF in tears significantly increased in the diabetes with DE group and positively correlated with the CFS and negatively correlated with the Schirmer I test in this group (P < .05). No differences were found in the levels of IL-17A, IL-1β, and TNF-α in the diabetes with DE and diabetes without DE groups compared to the normal group (P > .05). The nondiabetes with DE group showed increased levels of IL-17A, IL-1β, and TNF-α in tears compared to the normal group and the levels of IL-1β and TNF-α in tears positively correlated with CFS (P < .05). CONCLUSIONS: Our study showed that levels of EGF in tears have potential to be the diagnostic biomarker of DE in diabetes. No differences of IL-17A, IL-1β, and TNF-α in tears were found between the diabetes with DE and normal group, suggesting different pathogenesis of diabetes DE vs nondiabetes DE.
Authors: Muhammad Z Chauhan; Peyton A Rather; Sajida M Samarah; Abdelrahman M Elhusseiny; Ahmed B Sallam Journal: Cells Date: 2022-06-17 Impact factor: 7.666